Matt
Host, Gila Podcast
Matt handles the research side of the Gila podcast and writes most of Gila’s "what the study actually says" articles. He tracks new GLP-1 trials, medication approvals, cost dynamics, and the data coming out of the Gila pilot community.
On the podcast he is the one who pulls up the paper and reads the methodology out loud. In writing he translates research and news for GLP-1 users — always linking primary sources, always attributing uncertainty honestly.
Matt is not a clinician. Clinical claims in his articles are sourced to primary references inline.
What Matt writes about
- New GLP-1 study and trial breakdowns
- Drug approval and pipeline news
- Cost, insurance, and access analysis
- Pilot community data reports
- Methodology explainers and app/tool comparisons
Disclosure
Matt is a brand host of the Gila podcast. His portrait is an illustrative AI-generated image.
Articles bylined to Matt are written by the Gila editorial team and edited by our editor-in-chief, Sezen Soykut (ICF ACC).
Gila is a behavioral-science and GLP-1 news publisher — not a medical advisory service. For medical guidance, talk to your prescriber.
Editor-in-chief: Sezen Soykut, ICF ACC · Gila